Versant Ventures VII GP, L.P.
SEC CIK 1777655 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | 10% | 1.32M | — | $7.42M | 2 | 2025-08-22 | 2025-08-22 |
Most active insiders at LENZ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Versant Vantage II GP-GP, LLC | 10% | — | $10.35M |
| 2 | Olsson Shawn | Chief Commercial Off | — | $261.0K |
| 3 | Schimmelpennink Evert B. | Pres, CEO, Sec, Dir | $251.4K | — |
| 4 | MCCOLLUM JAMES W | Dir | $239.3K | — |
| 5 | Chevallard Daniel R. | CFO | $114.3K | — |
| 6 | George Jeffrey P. | Dir | $49.9K | — |
Versant Ventures VII GP, L.P. made no open-market trades at LENZ in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-26 | 2025-08-22+ | LENZ | LENZ Therapeutics, Inc. | Versant Ventures VII GP, L.P. | 10% | S - Sale | $39.47 | -126.0K | 1.32M | -9% | -$4.97M |
| MI | 2025-08-26 | 2025-08-22+ | LENZ | LENZ Therapeutics, Inc. | Versant Ventures VII GP, L.P. | 10% | S - Sale | $39.47 | -62.1K | 952.8K | -6% | -$2.45M |
Purchase Sale Sale after option exercise All abbreviations